Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

Nordic Life Science Insight's Logo
Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018
Finance

Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018

Novo Nordisk Pharmatech A/S
February 4, 2019

Operating profit increased by 6% measured in local currencies when adjusted for the cost of severance and the priority review voucher for oral semaglutide

Ten new incubator companies and over SEK 700 million in venture capital
Finance

Ten new incubator companies and over SEK 700 million in venture capital

SmiLe Incubator
January 31, 2019

In 2018 SmiLe met its annual goal of finding about ten new life science startup companies with a strong team, a high level of innovation and strong international market potential. SmiLe has thereby helped a total of 70 companies to develop their products for better health, including the current 22 member companies. Together, they have attracted a record amount of SEK 728 million in venture capital, 18 percent more than the previous year’s high figure.

SAGA awarded SEK 4.7 million Vinnova grant from Swelife
Finance

SAGA awarded SEK 4.7 million Vinnova grant from Swelife

SmiLe Incubator
November 26, 2018

SmiLe company Saga Diagnostics has been chosen following tough competition to be awarded a grant through Swelife’s “Project for better health, step 2” and will receive SEK 4.7 million. In addition to being a member of SmiLe Incubator, Saga is included in LU Holding’s portfolio of companies. Of the 22 projects that were evaluated, only eight receive funding and half of them come from Lund.

Sinntaxis secures Horizon 2020 grant to prepare for phase II trial in stroke recovery
Finance

Sinntaxis secures Horizon 2020 grant to prepare for phase II trial in stroke recovery

SmiLe Incubator
November 26, 2018

Sinntaxis in Lund has been awarded SEK 500,000 under the SME instrument phase 1 program within the EU Horizon 2020 framework. The grant money will be used to advance the business plan and the regulatory work to initiate a phase II clinical trial in stroke recovery.

AbbVie Donates $55 Million to Three Education Nonprofits Supporting Underserved Youth in Chicago & Across America
Finance

AbbVie Donates $55 Million to Three Education Nonprofits Supporting Underserved Youth in Chicago & Across America

AbbVie
November 20, 2018

‍Donations include $30 million to Communities In Schools, $10 million to City Year and $15 million to University of Chicago Education Lab. The contributions will significantly expand and strengthen programs to provide vulnerable children across the country with academic, social and emotional support to help them achieve their full potential.

Swedish Research Council gives In2cure project SEK 950,000 and highest grades
Finance

Swedish Research Council gives In2cure project SEK 950,000 and highest grades

SmiLe Incubator
November 15, 2018

In2cure’s founder has received SEK 950,000 from the Swedish Research Council for development of the drug candidate BioC, which will be used to promote wound healing. The In2cure project received consistently high scores in the Research Council’s assessment.

Date
Title
Author
November 7, 2018
InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2019 Annual General Meeting
InDex Pharmaceuticals
October 25, 2018
InDex Pharmaceuticals carries out a directed share issue of approximately SEK 37.5 million
InDex Pharmaceuticals
October 2, 2018
in2cure raises SEK 10 million
SmiLe Incubator
September 25, 2018
Curida attracts new investors
Curida AS
August 23, 2018
In need of start-up money?
Oslo Cancer Cluster
August 9, 2018
Novo Nordisk's operating profit decreased by 8% in Danish kroner and increased by 4% in local currencies in the first six months of 2018
Novo Nordisk Pharmatech A/S
May 2, 2018
AbbVie Commences Self-Tender Offer for Up to $7.5 Billion of its Common Stock
AbbVie
May 2, 2018
AbbVie Reports First-Quarter 2018 Financial Results
AbbVie
April 26, 2018
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2017
InDex Pharmaceuticals
April 26, 2018
InDex Pharmaceuticals Holding AB – Annual Report 2017
InDex Pharmaceuticals

Featured items

State of Medicon Valley 2018
State of Medicon Valley 2018
Medicon Valley Alliance
T-cells and the Nobel Price
T-cells and the Nobel Price
Oslo Cancer Cluster
The Life Science Industry – crucial for Sweden!
The Life Science Industry – crucial for Sweden!
Medicon Valley Alliance
Vessela Kristensen Receives Cancer Research Award
Vessela Kristensen Receives Cancer Research Award
Oslo Cancer Cluster
Strong presence of Nordic skills and innovations in life science at Arab Health 2018
Strong presence of Nordic skills and innovations in life science at Arab Health 2018
Global Pharma Consulting

Nordic Life Science - Insight

NLS Insight's goal is to assist the Nordic regions leading innovators in targeting business collaborations, parnership opportunities and investment potential.

info@nlsinsight.com
+47 69 51 02 XX
Olaf Helsets vei 5, 0694 Oslo
Mail iconinfo@nlsinsight.com
Phone Icon+47 69 51 01 94
Adress IconOlaf Helsets vei 5, 0694 Oslo
Facebook icon
Twitter icon
Privacy policy
Subscribe to
our newsletters

Designed by Horn Digital Media 2017